Mackenzie Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $88.9M | Buy |
1,465,433
+357,312
| +32% | +$20.8M | 0.11% | 169 |
|
|
2025
Q4 | $60M | Sell |
1,108,121
-146,350
| -12% | -$7.04M | 0.07% | 230 |
|
|
2025
Q3 | $56.6M | Buy |
1,254,471
+128,101
| +11% | +$5.98M | 0.07% | 232 |
|
|
2025
Q2 | $52.1M | Buy |
1,126,370
+225,794
| +25% | +$11.1M | 0.07% | 223 |
|
|
2025
Q1 | $54.9M | Buy |
900,576
+314,810
| +54% | +$18.3M | 0.08% | 203 |
|
|
2024
Q4 | $33.1M | Buy |
585,766
+267,843
| +84% | +$15M | 0.05% | 268 |
|
|
2024
Q3 | $16.4M | Sell |
317,923
-187,731
| -37% | -$8.81M | 0.02% | 373 |
|
|
2024
Q2 | $21M | Sell |
505,654
-77,522
| -13% | -$3.47M | 0.03% | 329 |
|
|
2024
Q1 | $31.6M | Sell |
583,176
-28,538
| -5% | -$1.45M | 0.05% | 275 |
|
|
2023
Q4 | $31.4M | Buy |
611,714
+168,135
| +38% | +$8.83M | 0.05% | 265 |
|
|
2023
Q3 | $25.4M | Sell |
443,579
-32,094
| -7% | -$1.97M | 0.04% | 283 |
|
|
2023
Q2 | $30.6M | Sell |
475,673
-210,116
| -31% | -$14.1M | 0.05% | 264 |
|
|
2023
Q1 | $47.5M | Buy |
685,789
+22,421
| +3% | +$1.58M | 0.07% | 231 |
|
|
2022
Q4 | $47.7M | Sell |
663,368
-38,250
| -5% | -$2.88M | 0.08% | 210 |
|
|
2022
Q3 | $49.9M | Buy |
701,618
+44,558
| +7% | +$3.23M | 0.09% | 204 |
|
|
2022
Q2 | $50.6M | Buy |
657,060
+318,497
| +94% | +$24.3M | 0.08% | 209 |
|
|
2022
Q1 | $24.7M | Buy |
338,563
+68,018
| +25% | +$4.57M | 0.03% | 319 |
|
|
2021
Q4 | $16.9M | Sell |
270,545
-55,758
| -17% | -$3.27M | 0.02% | 394 |
|
|
2021
Q3 | $19.3M | Buy |
326,303
+44,067
| +16% | +$2.9M | 0.03% | 353 |
|
|
2021
Q2 | $18.9M | Buy |
282,236
+24,998
| +10% | +$1.63M | 0.03% | 348 |
|
|
2021
Q1 | $16.2M | Buy |
257,238
+67,916
| +36% | +$4.23M | 0.02% | 347 |
|
|
2020
Q4 | $11.7M | Sell |
189,322
-2,084
| -1% | -$128K | 0.03% | 324 |
|
|
2020
Q3 | $11.5M | Sell |
191,406
-144
| -0.1% | -$8.67K | 0.03% | 286 |
|
|
2020
Q2 | $11.3M | Sell |
191,550
-61,176
| -24% | -$3.66M | 0.03% | 285 |
|
|
2020
Q1 | $14.1M | Buy |
252,726
+148,977
| +144% | +$9.11M | 0.05% | 240 |
|
|
2019
Q4 | $6.66M | Sell |
103,749
-156,928
| -60% | -$8.99M | 0.02% | 391 |
|
|
2019
Q3 | $13.2M | Sell |
260,677
-1,186
| -0.5% | -$55.7K | 0.03% | 289 |
|
|
2019
Q2 | $11.9M | Buy |
261,863
+31,096
| +13% | +$1.45M | 0.03% | 290 |
|
|
2019
Q1 | $11M | Buy |
230,767
+3,910
| +2% | +$195K | 0.03% | 357 |
|
|
2018
Q4 | $11.8M | Buy |
226,857
+103,988
| +85% | +$5.59M | 0.03% | 332 |
|
|
2018
Q3 | $7.63M | Buy |
122,869
+23,543
| +24% | +$1.4M | 0.02% | 395 |
|
|
2018
Q2 | $5.5M | Buy |
99,326
+17,214
| +21% | +$930K | 0.01% | 434 |
|
|
2018
Q1 | $5.19M | Buy |
82,112
+58,098
| +242% | +$3.74M | 0.01% | 431 |
|
|
2017
Q4 | $1.47M | Sell |
24,014
-75,041
| -76% | -$4.69M | ﹤0.01% | 565 |
|
|
2017
Q3 | $6.31M | Buy |
99,055
+12,980
| +15% | +$758K | 0.03% | 309 |
|
|
2017
Q2 | $4.8M | Buy |
86,075
+40,630
| +89% | +$2.21M | 0.03% | 317 |
|
|
2017
Q1 | $2.47M | Sell |
45,445
-5,698
| -11% | -$313K | 0.01% | 378 |
|
|
2016
Q4 | $2.99M | Buy |
+51,143
| New | +$2.8M | 0.02% | 337 |
|
|
2016
Q3 | – | Sell |
-186,335
| Closed | -$13.7M | – | 677 |
|
|
2016
Q2 | $13.7M | Sell |
186,335
-53,980
| -22% | -$3.81M | 0.08% | 222 |
|
|
2016
Q1 | $15.4M | Sell |
240,315
-32,850
| -12% | -$2.07M | 0.14% | 167 |
|
|
2015
Q4 | $18.8M | Buy |
273,165
+5,928
| +2% | +$392K | 0.12% | 173 |
|
|
2015
Q3 | $15.8M | Sell |
267,237
-30,330
| -10% | -$1.92M | 0.1% | 200 |
|
|
2015
Q2 | $19.8M | Sell |
297,567
-2,160
| -0.7% | -$142K | 0.11% | 189 |
|
|
2015
Q1 | $19.3M | Sell |
299,727
-13,636
| -4% | -$854K | 0.1% | 191 |
|
|
2014
Q4 | $18.5M | Sell |
313,363
-306,294
| -49% | -$17.3M | 0.09% | 180 |
|
|
2014
Q3 | $31.7M | Buy |
619,657
+326,370
| +111% | +$16.3M | 0.16% | 128 |
|
|
2014
Q2 | $14.2M | Buy |
293,287
+5,580
| +2% | +$275K | 0.07% | 232 |
|
|
2014
Q1 | $14.9M | Buy |
287,707
+4,853
| +2% | +$258K | 0.07% | 213 |
|
|
2013
Q4 | $15M | Sell |
282,854
-6,100
| -2% | -$311K | 0.08% | 211 |
|
|
2013
Q3 | $13.4M | Buy |
288,954
+81,140
| +39% | +$3.56M | 0.07% | 221 |
|
|
2013
Q2 | $9.29M | Buy |
+207,814
| New | +$9.02M | 0.04% | 262 |
|
Other funds holding BMY
VCM
VPM
Mackenzie Financial's BMY Position: Q1 2026 in Review
Mackenzie Financial increased its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, buying an estimated $20.8M and bringing the position to 1,465,433 shares worth $88.9M. The position accounts for 0.11% of the portfolio, ranked #169.
Mackenzie Financial first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Mackenzie Financial held 1,465,433 shares of Bristol-Myers Squibb worth $88.9M as of Q1 2026.
- Mackenzie Financial bought 357,312 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.8M.
- Bristol-Myers Squibb made up 0.11% of Mackenzie Financial's portfolio in Q1 2026, its #169 holding.
- Mackenzie Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.